The ultimate goal of treatment of cardiovascular disease is to restore normal heart structure and function. Cardiac transplantation is a treatment option for patients with progressive Cardiac Heart Failure (CSF) or certain cardiac diseases that are not amenable to conventional medical- surgical therapy. Patients who cannot meet developmental milestones or who have unacceptable quality of life issues may benefit from cardiac transplant surgery. However, approximately one in four patients die while waiting for an organ donor. Those patients who receive a donor heart must take lifelong immunosuppression medications to prevent rejection. However, in Mr. Barney Clarke’s case, a heart patient at the University of Utah, was at death’s